Caxton Associates (New York)’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,172	Closed	-$375K	–	619
2021 Q4	$375K	Buy	+3,172	New	+$375K	0.04%	326
2021 Q2	–	Sell	-3,940	Closed	-$316K	–	537
2021 Q1	$316K	Buy	+3,940	New	+$316K	0.03%	239